Animal models of Parkinson's disease
Identifieur interne : 001940 ( Main/Exploration ); précédent : 001939; suivant : 001941Animal models of Parkinson's disease
Auteurs : Ranjita Betarbet ; Todd B. Sherer ; J. Timothy GreenamyreSource :
- BioEssays [ 0265-9247 ] ; 2002-04.
Abstract
Animal models are important tools in experimental medical science to better understand pathogenesis of human diseases. Once developed, these models can be exploited to test therapeutic approaches for treating functional disturbances observed in the disease of interest. On the basis of experimental and clinical findings, Parkinson's disease (PD) was the first neurological disease to be modeled and, subsequently, to be treated by neurotransmitter replacement therapy. Agents that selectively disrupt or destroy catecholaminergic systems, such as reserpine, methamphetamine, 6‐hydroxydopamine and 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine have been used to develop PD models. Recently, it has been found that agricultural chemicals, such as rotenone and paraquat, when administered systemically, can reproduce specific features of PD in rodents, apparently via oxidative damage. Transgenic animals that over‐express α‐synuclein are used to study the role of this protein in dopaminergic degeneration. This review critically discusses animal models of PD and compares them with characteristics of the human disease. BioEssays 24:308–318, 2002. ©2002 Wiley Periodicals, Inc.
Url:
DOI: 10.1002/bies.10067
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Animal models of Parkinson's disease</title><author><name sortKey="Betarbet, Ranjita" sort="Betarbet, Ranjita" uniqKey="Betarbet R" first="Ranjita" last="Betarbet">Ranjita Betarbet</name></author><author><name sortKey="Sherer, Todd B" sort="Sherer, Todd B" uniqKey="Sherer T" first="Todd B." last="Sherer">Todd B. Sherer</name></author><author><name sortKey="Greenamyre, J Timothy" sort="Greenamyre, J Timothy" uniqKey="Greenamyre J" first="J. Timothy" last="Greenamyre">J. Timothy Greenamyre</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D489980D2A6C69584752E02E1CB7922836EED54F</idno><date when="2002" year="2002">2002</date><idno type="doi">10.1002/bies.10067</idno><idno type="url">https://api.istex.fr/document/D489980D2A6C69584752E02E1CB7922836EED54F/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">003111</idno><idno type="wicri:Area/Main/Curation">002D14</idno><idno type="wicri:Area/Main/Exploration">001940</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Animal models of Parkinson's disease</title><author><name sortKey="Betarbet, Ranjita" sort="Betarbet, Ranjita" uniqKey="Betarbet R" first="Ranjita" last="Betarbet">Ranjita Betarbet</name><affiliation><wicri:noCountry code="subField">Atlanta</wicri:noCountry></affiliation></author><author><name sortKey="Sherer, Todd B" sort="Sherer, Todd B" uniqKey="Sherer T" first="Todd B." last="Sherer">Todd B. Sherer</name><affiliation><wicri:noCountry code="subField">Atlanta</wicri:noCountry></affiliation></author><author><name sortKey="Greenamyre, J Timothy" sort="Greenamyre, J Timothy" uniqKey="Greenamyre J" first="J. Timothy" last="Greenamyre">J. Timothy Greenamyre</name><affiliation><wicri:noCountry code="subField">Atlanta</wicri:noCountry></affiliation></author></analytic><monogr></monogr><series><title level="j">BioEssays</title><title level="j" type="abbrev">Bioessays</title><idno type="ISSN">0265-9247</idno><idno type="eISSN">1521-1878</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>New York</pubPlace><date type="published" when="2002-04">2002-04</date><biblScope unit="volume">24</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="308">308</biblScope><biblScope unit="page" to="318">318</biblScope></imprint><idno type="ISSN">0265-9247</idno></series><idno type="istex">D489980D2A6C69584752E02E1CB7922836EED54F</idno><idno type="DOI">10.1002/bies.10067</idno><idno type="ArticleID">BIES10067</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0265-9247</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Animal models are important tools in experimental medical science to better understand pathogenesis of human diseases. Once developed, these models can be exploited to test therapeutic approaches for treating functional disturbances observed in the disease of interest. On the basis of experimental and clinical findings, Parkinson's disease (PD) was the first neurological disease to be modeled and, subsequently, to be treated by neurotransmitter replacement therapy. Agents that selectively disrupt or destroy catecholaminergic systems, such as reserpine, methamphetamine, 6‐hydroxydopamine and 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine have been used to develop PD models. Recently, it has been found that agricultural chemicals, such as rotenone and paraquat, when administered systemically, can reproduce specific features of PD in rodents, apparently via oxidative damage. Transgenic animals that over‐express α‐synuclein are used to study the role of this protein in dopaminergic degeneration. This review critically discusses animal models of PD and compares them with characteristics of the human disease. BioEssays 24:308–318, 2002. ©2002 Wiley Periodicals, Inc.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Betarbet, Ranjita" sort="Betarbet, Ranjita" uniqKey="Betarbet R" first="Ranjita" last="Betarbet">Ranjita Betarbet</name><name sortKey="Greenamyre, J Timothy" sort="Greenamyre, J Timothy" uniqKey="Greenamyre J" first="J. Timothy" last="Greenamyre">J. Timothy Greenamyre</name><name sortKey="Sherer, Todd B" sort="Sherer, Todd B" uniqKey="Sherer T" first="Todd B." last="Sherer">Todd B. Sherer</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001940 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001940 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:D489980D2A6C69584752E02E1CB7922836EED54F
|texte= Animal models of Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |